Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
9.55
-0.06 (-0.62%)
Dec 5, 2025, 4:00 PM EST - Market closed
Biohaven Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 111.98 | 89.24 | 62.77 | 130.86 | 37.41 | 16.05 |
| Research & Development | 669.69 | 784.97 | 373.28 | 437.07 | 181.49 | 98.46 |
| Operating Expenses | 781.68 | 874.21 | 436.05 | 567.93 | 218.9 | 114.51 |
| Operating Income | -781.68 | -874.21 | -436.05 | -567.93 | -218.9 | -114.51 |
| Earnings From Equity Investments | - | - | - | - | 5.26 | -4.16 |
| Other Non Operating Income (Expenses) | -4.45 | 18.09 | 8.81 | -5.12 | 1.21 | - |
| EBT Excluding Unusual Items | -786.13 | -856.12 | -427.24 | -573.05 | -212.43 | -118.67 |
| Gain (Loss) on Sale of Investments | 18.05 | 21.33 | 17.69 | 3.21 | - | - |
| Other Unusual Items | -10.9 | -10.9 | - | - | - | - |
| Pretax Income | -778.97 | -845.69 | -409.55 | -569.84 | -212.43 | -118.67 |
| Income Tax Expense | 1.14 | 0.74 | -1.38 | 0.44 | 1.37 | - |
| Net Income | -780.11 | -846.42 | -408.17 | -570.28 | -213.8 | -118.67 |
| Net Income to Common | -780.11 | -846.42 | -408.17 | -570.28 | -213.8 | -118.67 |
| Shares Outstanding (Basic) | 103 | 91 | 71 | 45 | 39 | 39 |
| Shares Outstanding (Diluted) | 103 | 91 | 71 | 45 | 39 | 39 |
| Shares Change (YoY) | 19.62% | 28.14% | 59.14% | 13.63% | - | - |
| EPS (Basic) | -7.59 | -9.28 | -5.73 | -12.75 | -5.43 | -3.01 |
| EPS (Diluted) | -7.59 | -9.28 | -5.73 | -12.75 | -5.43 | -3.01 |
| Free Cash Flow | -650.27 | -586.5 | -334.77 | -303.76 | -146.78 | -78.65 |
| Free Cash Flow Per Share | -6.32 | -6.43 | -4.70 | -6.79 | -3.73 | -2.00 |
| EBITDA | -771.87 | -866.36 | -429.14 | -566.55 | -217.51 | -114.43 |
| D&A For EBITDA | 9.81 | 7.86 | 6.91 | 1.39 | 1.39 | 0.07 |
| EBIT | -781.68 | -874.21 | -436.05 | -567.93 | -218.9 | -114.51 |
Source: S&P Capital IQ. Standard template.
Financial Sources.